Format

Send to

Choose Destination
Blood Rev. 2017 Nov;31(6):370-388. doi: 10.1016/j.blre.2017.07.003. Epub 2017 Jul 14.

The skin as a window to the blood: Cutaneous manifestations of myeloid malignancies.

Author information

1
Department of Dermatology, Yale School of Medicine, New Haven, USA.
2
Department of Medicine (Hematology), Yale School of Medicine, New Haven, USA.
3
Department of Dermatology, Yale School of Medicine, New Haven, USA. Electronic address: jonathan.leventhal@yale.edu.

Abstract

Cutaneous manifestations of myeloid malignancies are common and have a broad range of presentations. These skin findings are classified as specific, due to direct infiltration by malignant hematopoietic cells, or non-specific. Early recognition and diagnosis can have significant clinical implications, as skin manifestations may be the first indication of underlying hematologic malignancy, can reflect the immune status and stage of disease, and cutaneous reactions may occur from conventional and targeted agents used to treat myeloid disease. In addition, infections with cutaneous involvement are common in immunocompromised patients with myeloid disease. Given the varying presentations, dermatologic findings associated with myeloid malignancies can pose diagnostic challenges for hematologists and dermatologists. In this clinical review intended for the practicing hematologist/oncologist, we discuss the presentation, diagnosis, treatment, and prognostic value of the most common cutaneous manifestations associated with myeloid malignancies using illustrative macro- and microscopic figures and with a special emphasis on practical considerations.

KEYWORDS:

Dermatology; Leukemia; Leukemia cutis; Myeloid malignancies; Paraneoplastic; Skin

PMID:
28732587
DOI:
10.1016/j.blre.2017.07.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center